Sezai Vatansever
Impact in
-
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cancer Cells and Metastasis
Papers in
- Oncology 19
- HER2/EGFR in Cancer Research 3
- Lung Cancer Research Studies 3
- Cancer Immunotherapy and Biomarkers 3
-
- Lung Cancer Treatments and Mutations 4
- Lung Cancer Diagnosis and Treatment 3
- Co-authors
- Faruk Taş (11 shared papers)Murat Serilmez (5 shared papers)Senem Karabulut (11 shared papers)Serkan Keskın (7 shared papers)Didem Taştekin (4 shared papers)Şükrü Palanduz (5 shared papers)Kıvanç Çefle (5 shared papers)Halim İşsever (2 shared papers)
- Journals
- Tumor Biology (7 papers)Oncology (2 papers)Journal of Clinical Oncology (2 papers)Chemotherapy (1 paper)Molecular Biology Reports (1 paper)
- Partner nations
- Türkiye
In The Last Decade
Sezai Vatansever
50 papers receiving 300 citations
Peers
Comparison fields: 5 of 67
- Hepatology 23
- Oncology 68
- Health, Toxicology and Mutagenesis 35
- Cancer Research 33
- Immunology and Allergy 10
Countries citing papers authored by Sezai Vatansever
This map shows the geographic impact of Sezai Vatansever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sezai Vatansever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sezai Vatansever more than expected).
Fields of papers citing papers by Sezai Vatansever
This network shows the impact of papers produced by Sezai Vatansever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sezai Vatansever. The network helps show where Sezai Vatansever may publish in the future.
Co-authors
The 25 scholars most cited alongside Sezai Vatansever, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 19 | |
| 2 | 2014 | 19 | |
| 3 | 2014 | 18 | |
| 4 | 2013 | 16 | |
| 5 | 2014 | 16 | |
| 6 | 2015 | 16 | |
| 7 | 2006 | 15 | |
| 8 | 2005 | 14 | |
| 9 | 2002 | 14 | |
| 10 | 2013 | 12 | |
| 11 | 2008 | 12 | |
| 12 | 2000 | 9 | |
| 13 | 2021 | 9 | |
| 14 | 2000 | 8 | |
| 15 | 2023 | 8 | |
| 16 | Rheological properties of blood in patients with chronic liver disease. | 2002 | 8 |
| 17 | Sister chromatid exchange and mitotic index in patients with cirrhosis related to hepatitis B and C viruses and in chronic carriers. | 2004 | 7 |
| 18 | 2013 | 7 | |
| 19 | High sensitivity C-reactive protein in spontaneous bacterial peritonitis with nonneutrocytic ascites. | 2009 | 7 |
| 20 | 2021 | 6 |
About Sezai Vatansever
Sezai Vatansever is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Epidemiology, having authored 53 papers that have together received 305 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), HER2/EGFR in Cancer Research (3 papers), Lung Cancer Research Studies (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Air Quality and Health Impacts (2 papers) and Heme Oxygenase-1 and Carbon Monoxide (2 papers). The work is most often cited by research in Hepatology (23 citations), Oncology (68 citations), Health, Toxicology and Mutagenesis (35 citations), Cancer Research (33 citations) and Immunology and Allergy (10 citations). Sezai Vatansever has collaborated with scholars based in Türkiye. Frequent co-authors include Faruk Taş, Murat Serilmez, Senem Karabulut, Serkan Keskın, Didem Taştekin, Şükrü Palanduz, Kıvanç Çefle, Halim İşsever, Derya Duranyıldız and Rian Dişçi. Their work appears in journals such as Tumor Biology, Oncology, Journal of Clinical Oncology, Chemotherapy and Molecular Biology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.